Literature DB >> 12057167

Ewing's sarcoma.

P A Meyers1, A S Levy.   

Abstract

Patients with Ewing's sarcoma should be transferred to a comprehensive cancer center for evaluation and management when the diagnosis is suspected. Proper biopsy technique is essential to preserve all therapeutic options, including limb preservation surgery. In addition to conventional histologic examination, biopsy tissue must be obtained for molecular biology studies. Demonstration of the consistent chromosomal translocation associated with Ewing's sarcoma is essential for diagnosis, and the specific type of fusion transcript has prognostic implications. Treatment must be intimately coordinated among oncologist, surgeon, and radiation oncologist. Successful treatment requires systemic, multi-agent chemotherapy and local control. The primary tumor can be treated with surgery, radiation therapy, or a combination of the two. The choice of modality should be dictated by the age of the patient, location of the primary tumor, functional consequences of the intervention, and concern about late effects, especially secondary malignancy. Treatment of the patient who presents with clinically detectable metastatic disease or who relapses after initial therapy remains unsatisfactory and controversial.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12057167     DOI: 10.1007/s11864-000-0036-7

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  13 in total

1.  Unicolor and bicolor in situ hybridization in the diagnosis of peripheral neuroepithelioma and related tumors.

Authors:  C Desmaze; J Zucman; O Delattre; G Thomas; A Aurias
Journal:  Genes Chromosomes Cancer       Date:  1992-07       Impact factor: 5.006

2.  Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.

Authors:  K B Hahm; K Cho; C Lee; Y H Im; J Chang; S G Choi; P H Sorensen; C J Thiele; S J Kim
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

3.  Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.

Authors:  J F Kuttesch; L H Wexler; R B Marcus; D Fairclough; L Weaver-McClure; M White; L Mao; T F Delaney; C B Pratt; M E Horowitz; L E Kun
Journal:  J Clin Oncol       Date:  1996-10       Impact factor: 44.544

4.  Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma.

Authors:  T E Merchant; B H Kushner; J M Sheldon; M LaQuaglia; J H Healey
Journal:  Med Pediatr Oncol       Date:  1999-08

5.  Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors.

Authors:  C Desmaze; F Brizard; C Turc-Carel; T Melot; O Delattre; G Thomas; A Aurias
Journal:  Cancer Genet Cytogenet       Date:  1997-08

6.  Radiation therapy as local treatment in Ewing's sarcoma. Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86.

Authors:  J Dunst; R Sauer; J M Burgers; R Hawliczek; R Kürten; W Winkelmann; M Salzer-Kuntschik; M Müschenich; H Jürgens
Journal:  Cancer       Date:  1991-06-01       Impact factor: 6.860

7.  Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.

Authors:  S Burdach; H Jürgens; C Peters; W Nürnberger; C Mauz-Körholz; D Körholz; M Paulussen; H Pape; D Dilloo; E Koscielniak
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

8.  The management of Ewing's sarcoma: role of radiotherapy in local tumor control.

Authors:  P R Thomas; C A Perez; J R Neff; M E Nesbit; R G Evans
Journal:  Cancer Treat Rep       Date:  1984-05

9.  EWS rearrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression.

Authors:  M Ladanyi; R Lewis; P Garin-Chesa; W J Rettig; A G Huvos; J H Healey; S C Jhanwar
Journal:  Diagn Mol Pathol       Date:  1993-09

10.  No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.

Authors:  O Oberlin; J L Habrand; J M Zucker; M Brunat-Mentigny; M J Terrier-Lacombe; J Dubousset; J C Gentet; C Schmitt; D Ponvert; C Carrié
Journal:  J Clin Oncol       Date:  1992-09       Impact factor: 44.544

View more
  1 in total

Review 1.  Recent advances in the molecular pathogenesis of Ewing's sarcoma.

Authors:  E C Toomey; J D Schiffman; S L Lessnick
Journal:  Oncogene       Date:  2010-06-14       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.